Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase (Q44195803)

30 November 2017

title

Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase (English)

1 reference

30 November 2017

1 reference

30 November 2017

Zhigang Zhou

1 reference

30 November 2017

Marcela Madrid

series ordinal

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

30 November 2017

1 reference

30 November 2017

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

529-542

1 reference

HIV reverse transcriptase structure-function relationships

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Retroviral Reverse Transcription and Integration: Progress and Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

High resolution structures of HIV-1 RT from four RT-inhibitor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA template-primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Prediction of Binding Affinities for TIBO Inhibitors of HIV-1 Reverse Transcriptase Using Monte Carlo Simulations in a Linear Response Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Prediction of the binding free energies of new TIBO-like HIV-1 reverse transcriptase inhibitors using a combination of PROFEC, PB/SA, CMC/MD, and free energy calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Molecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Anti-AIDS Agents, 4. Tripterifordin, a Novel Anti-HIV Principle from Tripterygium wilfordii: Isolation and Structural Elucidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Anti-AIDS agents--XIX. Neotripterifordin, a novel anti-HIV principle from Tripterygium wilfordii: isolation and structural elucidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Bioactive kaurane diterpenoids from Annona glabra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Docking of sulfonamides to carbonic anhydrase II and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Ordered water and ligand mobility in the HIV-1 integrase-5CITEP complex: a molecular dynamics study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Comparison of three different crystal forms shows HIV-1 reverse transcriptase displays an internal swivel motion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Major subdomain rearrangement in HIV-1 reverse transcriptase simulated by molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Docking experiments in the flexible non-nucleoside inhibitor binding pocket of HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

Potamogetonin, a new furanoid diterpene. Structural assignment by carbon-13 and proton magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10233

21 January 2018

Identifiers

DOI

10.1002/PROT.10233

1 reference

30 November 2017

1 reference